The adult form of attention-deficit/hyperactivity disorder has a prevalence of up to 5% and is
the most severe long-term outcome of this common disorder. Family studies in clinical …

Attention-deficit/hyperactivity disorder (ADHD) is a common and highly heritable
neurodevelopmental disorder. In recent years, genetic studies have revealed several risk …

The onset of attention-deficit-hyperactivity-disorder (ADHD) in childhood is characterized by
developmentally inappropriate levels of hyperactivity, impulsivity and inattention. A chronic …

Abstract Tryptophan hydroxylase 2 (TPH2) is the rate-limiting enzyme in brain serotonin
synthesis. The TPH2 gene has frequently been investigated in relation to psychiatric …

Multiple biological processes throughout development require intracellular vesicular
trafficking, where the SNARE (soluble N-ethylmaleimide-sensitive factor (NSF) attachment …

The relationship between dopamine (DA) tone in the prefrontal cortex (PFC) and PFC-
dependent cognitive functions (for example, working memory, selective attention, executive …

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a
childhood prevalence of 5%. In about two-thirds of the cases, ADHD symptoms persist into …

Attention‐deficit/hyperactivity disorder (ADHD) is a complex and heterogeneous disorder,
affecting individuals across the life cycle. Although its etiology is not yet completely …

Overview Methylphenidate (MPH) is a central nervous system stimulant primarily used for
the treatment of attention deficit hyperactivity disorder (ADHD). MPH works by preventing the …

Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopment disorder occurring
during childhood. However, ADHD persists into adulthood in 45.7% of cases. The global …